Category: Forbes

Study: This Is How Much Your Risk Of Causing A Car Crash Increases When You Don’t Get Enough Sleep

Inadequate sleep increases the risk of causing a car crash beyond what most of us would guess, according to new research showing that poor sleep and driving is a truly dangerous combination.

The New Weight Watchers Doesn’t Want To Talk About Weight — WW Is All About Wellness

Weight Watchers announced a major rebrand as “WW” this week. Mindy Grossman, CEO and president of the company, discusses what the change means for the shifting landscape of wellness.

Abolishing Drug Rebates May Push Consumer Drug Costs Higher

The Administration’s intent to curtail the ability of pharmacy benefit managers to negotiate lower drug prices will do nothing to reduce the high costs of prescription drugs.

How These Founders Raised Funding From Hollywood

What does it take to build the “GOOP” of cannabis? This entrepreneurial duo reveals how they got Hollywood investors to back them from the start.

Apple, Google, Microsoft, Amazon And Facebook Own Huge Market Shares = Technology Oligarchy

The largest companies in the world are technology companies and the largest technology companies own huge market shares in their spaces. In fact, their market shares are growing. All this spells technology oligarchy. Good or bad?

Rajiv Mehta: Bringing Change For Caregivers

Rajiv Mehta, a 2018 Influencer in Aging, is the founder of Atlas of Caregiving, a nonprofit whose mission is to bring about change for family caregivers.

Chinese Drug Maker Clarifies Development Strategy For Bringing Cancer Drug To The U.S. Market

Given these plans, Chi-Med is open to U.S. partnerships for development of cancer therapies that incorporate fruquintinib.

Chinese Drug Maker Clarifies Development Strategy For Bringing Cancer Drug To The U.S. Market

Given these plans, Chi-Med is open to U.S. partnerships for development of cancer therapies that incorporate fruquintinib.

Chinese Drug Maker Clarifies Development Strategy For Bringing Cancer Drug To The U.S. Market

Given these plans, Chi-Med is open to U.S. partnerships for development of cancer therapies that incorporate fruquintinib.

Big Pharma Boosts Drug Prices As Supplies Run Low, Study Reveals

Drug companies display “opportunistic behavior” while pricing products that are in short supply, the authors of a new study allege.